AU2001256527A1 - Lead molecule generation - Google Patents

Lead molecule generation

Info

Publication number
AU2001256527A1
AU2001256527A1 AU2001256527A AU5652701A AU2001256527A1 AU 2001256527 A1 AU2001256527 A1 AU 2001256527A1 AU 2001256527 A AU2001256527 A AU 2001256527A AU 5652701 A AU5652701 A AU 5652701A AU 2001256527 A1 AU2001256527 A1 AU 2001256527A1
Authority
AU
Australia
Prior art keywords
molecule generation
lead molecule
lead
generation
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256527A
Inventor
Ahwing Edith Chan
Roman Aleksander Laskowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharmatica Ltd
Original Assignee
Inpharmatica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharmatica Ltd filed Critical Inpharmatica Ltd
Publication of AU2001256527A1 publication Critical patent/AU2001256527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
AU2001256527A 2000-05-16 2001-05-16 Lead molecule generation Abandoned AU2001256527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0011818 2000-05-16
GBGB0011818.2A GB0011818D0 (en) 2000-05-16 2000-05-16 Lead molecule generation
PCT/GB2001/002177 WO2001088847A2 (en) 2000-05-16 2001-05-16 Lead molecule generation

Publications (1)

Publication Number Publication Date
AU2001256527A1 true AU2001256527A1 (en) 2001-11-26

Family

ID=9891716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256527A Abandoned AU2001256527A1 (en) 2000-05-16 2001-05-16 Lead molecule generation

Country Status (5)

Country Link
US (1) US20030180803A1 (en)
EP (1) EP1282826A2 (en)
AU (1) AU2001256527A1 (en)
GB (1) GB0011818D0 (en)
WO (1) WO2001088847A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7203683B2 (en) * 2001-10-11 2007-04-10 Emerald Biostructures, Inc. Method and a system for automating the execution of AMoRe over a heterogenous network of computers
WO2005084193A2 (en) * 2004-02-24 2005-09-15 The Board Of Trustees Of The Leland Stanford Junior University Method for identifying a site of protein-protein interaction for the rational design of short peptides that interfere with that interaction
US20090006040A1 (en) * 2007-05-24 2009-01-01 Peter Hrnciar Systems and Methods for Representing Protein Binding Sites and Identifying Molecules with Biological Activity
US20140258207A1 (en) * 2013-03-07 2014-09-11 The Trustees Of Columbia University In The City Of New York Systems and Methods for Predicting Protein-Ligand Interactions
GB201310544D0 (en) * 2013-06-13 2013-07-31 Ucb Pharma Sa Obtaining an improved therapeutic ligand
CN111435608B (en) * 2019-09-05 2024-02-06 中国海洋大学 Protein drug binding site prediction method based on deep learning

Also Published As

Publication number Publication date
US20030180803A1 (en) 2003-09-25
GB0011818D0 (en) 2000-07-05
WO2001088847A2 (en) 2001-11-22
EP1282826A2 (en) 2003-02-12
WO2001088847A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2002222746A1 (en) An electro-motion toothbrush
AU4107001A (en) Toothbrush
AU2001228708A1 (en) Coin-validation arrangement
AU2001262847A1 (en) Language-understanding
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001265089A1 (en) Rc-timer scheme
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001284386A1 (en) Hydrogen motor
AU2001258924A1 (en) Microsatellite-aflp
AU2002212132A1 (en) Toothbrush housing
AU2001267963A1 (en) Improved dynamo
AU2001240791A1 (en) Sequence
AU2001256527A1 (en) Lead molecule generation
AU2001246864A1 (en) Hypotensors
AU2001210118A1 (en) Toothbrush
AU2001262206A1 (en) Toothbrush
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001260192A1 (en) Glycinamides
AU2001249886A1 (en) High q structure
AU2001236316A1 (en) Rotor
AU2001264307A1 (en) Envelope
AU2001275014A1 (en) Imidazoloisoquinolines